Biotech Companies Are Opening Manufacturing Sites in Africa: Will This Help Vaccine Equity?
If pharma giants truly are committed to addressing vaccine inequity, just building manufacturing capacity in Africa might not be enough.

If pharma giants truly are committed to addressing vaccine inequity, just building manufacturing capacity in Africa might not be enough.

The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines.
